ENDRA Life Sciences Gross Profit

ENDRA Life Sciences (NDRA) currently reports a gross profit of $0 as of June 2026. In the prior-year period, the figure was $0. That is below the Technology sector average of $260B. Use the charts on this page to explore ENDRA Life Sciences's gross profit history and peer comparisons.

ENDRA Life Sciences's gross profit changed from $0 to $0 (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

ENDRA Life Sciences's gross profit of $0 is lower than the Technology sector average of $260B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

ENDRA Life Sciences reported $0 in gross profit as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current gross profit of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. The Technology average is $260B. From there, open related valuation or income-statement pages for ENDRA Life Sciences, and consider following NDRA for alerts when major investors trade the stock.